Mphasis delivered strong Q1 FY2026 results with total income of ₹4,384.05 crore, representing a 17.46% year-on-year growth from ₹3,422.46 crore in Q1 FY2025. The software company's operating profit reached ₹648.11 crore with a 13.52% YoY increase, while profit after tax stood at ₹489.51 crore showing a 10.82% year-on-year growth. However, the company's operating margin compressed to 14.78% from 18.17% in the previous year, indicating margin pressure despite revenue expansion.
Frontline indices, the Sensex and the Nifty 50, declined up to half a per cent in morning trade on Tuesday, 11 August, amid persistent uncertainty over a peace deal between the US and Iran and the reopening of the Strait of Hormuz. According to Vishnu Kant Upadhyay of Master Capital Services, the Nifty 50 remains in the consolidation phase for six consecutive sessions, oscillating within the 24,500-24,700 range. On Tuesday morning, the index declined below 24,500 - an important short-term support where repeated buying interest was seen. Going forward, 24,400-24,500 remains a crucial support zone, while 24,650-24,700 is likely to act as immediate resistance on the upside.
Vishnu Kant Upadhyay of Master Capital Services and Hitesh Tailor of Choice Broking recommend the following six stocks for the next 1-2 weeks. According to Upadhyay, Mphasis shares have witnessed a strong trend reversal following a prolonged corrective phase, with a decisive breakout from a symmetrical triangle pattern indicating a shift in short-term momentum. The stock is recommended with target prices of ₹2,680 and ₹2,724 and a stop loss at ₹2,340. Poly Medicure is recommended with target prices of ₹1,900 and ₹1,950 and a stop loss at ₹1,665, while Syrma SGS Technology is suggested with target prices of ₹1,645 and ₹1,680 and a stop loss at ₹1,405.
As per Tailor from Choice Broking, Asian Paints is demonstrating strong bullish market structure, forming a series of higher highs and higher lows on the daily chart. The stock is comfortably trading above its key exponential moving averages - the 20, 50, 100, and 200 EMAs - confirming robust upward momentum. Healthcare Global Enterprises (HCG) is exhibiting strong bullish momentum following a sharp range breakout, with the stock trading comfortably above all major moving averages including its 20, 50, 100, and 200 EMAs. Meanwhile, Gujarat Mineral Development Corporation (GMDC) has delivered a sharp trendline breakout, signalling a potential reversal from its prior corrective phase and reclaiming crucial moving averages.
All expert recommendations include specific stop-loss levels for risk management. For Mphasis, the stop loss is set at ₹2,340 for target prices of ₹2,680 and ₹2,724. Poly Medicure has a stop loss at ₹1,665 for target prices of ₹1,900 and ₹1,950. Syrma SGS Technology has a stop loss at ₹1,405 for target prices of ₹1,645 and ₹1,680. Asian Paints targets ₹3,000 with a stop loss at ₹2,600, while Healthcare Global Enterprises targets ₹780 with a stop loss at ₹675. Gujarat Mineral Development Corporation targets ₹650 with a stop loss at ₹575.
